Versant Vantage I GP-GP, LLC
- SEC CIK
- 0001777653
No open-market purchases or sales filed in the past year.
Current role at each company
- LVTX LAVA Therapeutics NV10% Owneras of Sep 23, 2025
- GLUE Monte Rosa Therapeutics, Inc.10% Owneras of Oct 30, 2024
- CTNM Contineum Therapeutics, Inc.10% Owneras of Apr 11, 2024
- OYST Oyster Point Pharma, Inc.10% Owneras of Jan 4, 2023
- RPTX Repare Therapeutics Inc.10% Owneras of Jun 7, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Versant Vantage I GP-GP, LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LVTX LAVA Therapeutics NV
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2025 (view filing)4:33 PM ET | Sep 19 | 4 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −2.37M | $1.40 | −$3.32M | −100.0%0 after | |
| Sep 23, 2025 (view filing)4:33 PM ET | Sep 19 | 4 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −532.9K | $1.40 | −$746.8K | −100.0%0 after | |
| Sep 18, 2025 (view filing)6:49 PM ET | Sep 16-18 | 2 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −1.04M | $1.49 | −$1.54M | −30.4%2.37M after | 3 lots |
| Sep 18, 2025 (view filing)6:49 PM ET | Sep 16-18 | 2 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −647.8K | $1.49 | −$962.3K | −54.9%532.9K after | 3 lots |
GLUE Monte Rosa Therapeutics, Inc.
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 30, 2024 (view filing)4:35 PM ET | Oct 28-29 | 2 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −157.9K | $9.44 | −$1.49M | −9.1%1.57M after | 3 lots |
| Sep 24, 2024 (view filing)4:40 PM ET | Sep 20 | 4 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −1.13M | $6.53 | −$7.40M | −18.2%5.10M after | |
| Sep 13, 2024 (view filing)6:44 PM ET | Sep 11-13 | 2 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | SSale | −567.2K | $6.00 | −$3.40M | −8.3%6.23M after | 3 lots |
RPTX Repare Therapeutics Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 (view filing)4:37 PM ET | Jun 3 | 4 days | Versant Vantage I, L.P. and 2 others10% Owner | SSale | −750.0K | $12.25 | −$9.19M | −87.1%111.5K after | 5 lotsDuplicate filing |
OYST Oyster Point Pharma, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2021 (view filing)4:38 PM ET | Oct 18 | 2 days | Versant Ventures IV, LLC and 8 others10% Owner | SSale | −550.0K | $14.84 | −$8.16M | −99.1%4.99K after | 4 lots |